Seoul Pharma Co., Ltd (KOSDAQ:018680)

SolarWinds Revenue

Seoul Pharma had revenue of 12.89B KRW in the quarter ending March 31, 2025, a decrease of -4.04%. This brings the company's revenue in the last twelve months to 53.04B, down -0.59% year-over-year. In the year 2024, Seoul Pharma had annual revenue of 53.58B with 2.14% growth.

• Revenue (ttm): 53.04B
• Revenue Growth: -0.59%
• P/S Ratio: 0.73
• Revenue / Employee: 308.35M
• Employees: 172
• Market Cap: 38.94B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	53.58B	1.12B	2.14%
Dec 31, 2023	52.46B	2.40B	4.80%
Dec 31, 2022	50.06B	9.59B	23.71%
Dec 31, 2021	40.46B	-11.77B	-22.53%
Dec 31, 2020	52.23B	-1.72B	-3.19%